Reducing human exposure to mycobacterium avium

Annals of the American Thoracic Society

Volumn 10, Issue 4, 2013, Pages 378-382

  Falkinham, Joseph O ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Aerosols; Filters; Households; Temperature; Water

Indexed keywords

ACTIVATED CARBON; HOT WATER;

AEROSOL; ATYPICAL MYCOBACTERIOSIS; BACTERIAL GROWTH; BACTERIAL TRANSMISSION; BEHAVIOR CHANGE; ECOLOGY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL TEMPERATURE; GARDENING; HABITAT; HUMAN; LUNG DISEASE; MYCOBACTERIUM AVIUM; NONHUMAN; PREVALENCE; REVIEW; SOIL;

ENVIRONMENTAL EXPOSURE; FILTRATION; HOT TEMPERATURE; HUMANS; INHALATION EXPOSURE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; OPPORTUNISTIC INFECTIONS; PNEUMONIA, BACTERIAL; SOIL MICROBIOLOGY; WATER MICROBIOLOGY;

EID: 84883436006     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201301-013FR     Document Type: Review

References (48)

1. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence ofpulmonary non-tuberculous mycobacteria in Ontario, 1997 2003.Thorax 2007;62: 661-666.
2. Billinger ME, Olivier KN, Viboud C, de Oca RM, Steiner C, Holland SM, Prevots DR. Nontuberculous mycobacteria-associated lung diseasein hospitalized persons, United States, 1998-2005. Emerg InfectDis 2009;15: 1562-1569.
3. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE. Infection with Mycobacterium avium complexin patients without predisposing conditions. N Engl J Med 1989;321: 863-868.
4. Reich JM, Johnson RE. Mycobacterium avium complex pulmonarydisease: incidence, presentation, and response to therapy ina community setting. Am Rev Respir Dis 1991;143: 1381-1385.
5. Kennedy TP, Weber DJ. Nontuberculous mycobacteria: anunderappreciated cause of geriatric lung disease. Am J Respir CritCare Med 1994;149: 1654-1658.
6. Chan ED, Iseman MD. Slender, older women appear to be moresusceptible to nontuberculous mycobacterial lung disease. GendMed 2010;7: 5-18.
7. Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, et al. Pulmonarynontuberculous mycobacterial disease: prospective study ofa distinct preexisting syndrome. Am J Respir Crit Care Med 2008;178: 1066-1074.
8. Kim JS, Tanaka N, Newell JD, Degroote MA, Fulton K, Huitt G, LynchDA. Nontuberculous mycobacterial infection: CT scan findings, genotype, and treatment responsiveness. Chest 2005;128: 3863-3869.
9. Witty LA, Tapson VF, Piantadosi CA. Isolation of mycobacteria inpatients with pulmonary alveolar proteinosis. Medicine (Baltimore)1994;73: 103-109.
10. Thomson RM, Armstrong JG, Looke DF. Gastroesophageal refluxdisease, acid suppression, and Mycobacterium avium complexpulmonary disease. Chest 2007;131: 1166-1172.
11. Takahashi M, Ishizaka A, Nakamura H, Kobayashi K, Nakamura M, Namiki M, Sekita T, Okajima S. Specific HLA in pulmonary MACinfection in a Japanese population. Am J Respir Crit Care Med 2000;162: 316-318.
12. Wallace RJ Jr, Zhang Y, Brown-Elliott BA, Yakrus MA, Wilson RW, Mann L, Couch L, Girard WM, Griffith DE. Repeat positive cultures inMycobacterium intracellulare lung disease after macrolide therapyrepresent new infections in patients with nodular bronchiectasis.J Infect Dis 2002;186: 266-273.
13. Kirschner RA Jr, Parker BC, Falkinham JO III. Epidemiology ofinfection by nontuberculous mycobacteria: Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum inacid, brown-water swamps of the southeastern United States andtheir association with environmental variables. Am Rev Respir Dis1992;145: 271-275.
14. Falkinham JO III, Parker BC, Gruft H. Epidemiology of infection bynontuberculous mycobacteria: I. Geographic distribution in theeastern United States. Am Rev Respir Dis 1980;121: 931-937.
15. Covert TC, Rodgers MR, Reyes AL, Stelma GN Jr. Occurrence ofnontuberculous mycobacteria in environmental samples. ApplEnviron Microbiol 1999;65: 2492-2496.
16. Falkinham JO III, Norton CD, LeChevallier MW. Factors influencingnumbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. ApplEnviron Microbiol 2001;67: 1225-1231.
17. Falkinham JO III. Nontuberculous mycobacteria from householdplumbing of patients with nontuberculous mycobacteria disease.Emerg Infect Dis 2011;17: 419-424.
18. Nishiuchi Y, Maekura R, Kitada S, Tamaru A, Taguri T, Kira Y, Hiraga T, Hirotani A, Yoshimura K, Miki M, et al. The recovery ofMycobacterium avium-intracellulare complex (MAC) from theresidential bathrooms of patients with pulmonary MAC. Clin InfectDis 2007;45: 347-351.
19. Falkinham JO III, Iseman MD, de Haas P, van Soolingen D.Mycobacterium avium in a shower linked to pulmonary disease.J Water Health 2008;6: 209-213.
20. Feazel LM, Baumgartner LK, Peterson KL, Frank DN, Harris JK, PaceNR. Opportunistic pathogens enriched in showerhead biofilms. ProcNatl Acad Sci USA 2009;106: 16393-16399.
21. Dirac MA, Horan KL, Doody DR, Meschke JS, Park DR, Jackson LA, Weiss NS, Winthrop KL, Cangelosi GA. Environment or host? Acase-control study of risk factors for Mycobacterium avium complexlung disease. Am J Respir Crit Care Med 2012;186: 684-691.
22. Brennan PJ, Nikaido H. The envelope of mycobacteria. Annu RevBiochem 1995;64: 29-63.
23. Daffe M, Draper P. The envelope layers of mycobacteria with referenceto their pathogenicity. Adv Microb Physiol 1998;39: 131-203.
24. Jarlier V, Nikaido H. Mycobacterial cell wall: structure and role in naturalresistance to antibiotics. FEMS Microbiol Lett 1994;123: 11-18.
25. Taylor RM, Norton CD, LeChevallier MW, Falkinham JO III.Susceptibility of Mycobacterium avium, Mycobacteriumintracellulare, and Mycobacterium scrofulaceum to chlorine, chloramine, chlorine dioxide, and ozone. Appl Environ Microbiol2000;66: 1702-1705.
26. Rastogi N, Frehel C, Ryter A, Ohayon H, Lesourd M, David HL. Multipledrug resistance in Mycobacterium avium: is the wall architectureresponsible for exclusion of antimicrobial agents? Antimicrob Agents Chemother 1981;20: 666-677.
27. Torvinen E, Suomalainen S, Lehtola MJ, Miettinen IT, Zacheus O, Paulin L, Katila M-L, Martikainen PJ. Mycobacteria in water andloose deposits of drinking water distribution systems in Finland.Appl Environ Microbiol 2004;70: 1973-1981.
28. George KL, Parker BC, Gruft H, Falkinham JO III. Epidemiology ofinfection by nontuberculous mycobacteria: II. Growth and survival innatural waters. Am Rev Respir Dis 1980;122: 89-94.
29. Norton CD, LeChevallier MW, Falkinham JO III. Survival ofMycobacterium avium in a model distribution system. Water Res2004;38: 1457-1466.
30. Schulze-Röbbecke R, Buchholtz K. Heat susceptibility of aquaticmycobacteria. Appl Environ Microbiol 1992;58: 1869-1873.
31. Tichenor WS, Thurlow J, McNulty S, Brown-Elliott BA, Wallace RJ Jr, Falkinham JO III. Nontuberculous Mycobacteria in householdplumbing as possible cause of chronic rhinosinusitis. Emerg InfectDis 2012;18: 1612-1617.
32. Portaels F, Pattyn SR. Growth of mycobacteria in relation to the pH ofthe medium. Ann Microbiol (Paris) 1982;133: 213-221.
33. Bodmer T, Miltner E, Bermudez LE. Mycobacterium avium resistsexposure to the acidic conditions of the stomach. FEMS MicrobiolLett 2000;182: 45-49.
34. Kirschner RA Jr, Parker BC, Falkinham JO III. Humic and fulvic acidsstimulate the growth of Mycobacterium avium. FEMS Microbiol Ecol1999;30: 327-332.
35. Wendt SL, George KL, Parker BC, Gruft H, Falkinham JO III.Epidemiology of infection by nontuberculous Mycobacteria: III .Isolation of potentially pathogenic mycobacteria from aerosols. Am Rev Respir Dis 1980;122: 259-263.
36. Parker BC, Ford MA, Gruft H, Falkinham JO III. Epidemiology ofinfection by nontuberculous mycobacteria: IV. Preferentialaerosolization of Mycobacterium intracellulare from natural waters.Am Rev Respir Dis 1983;128: 652-656.
37. De Groote MA, Pace NR, Fulton K, Falkinham JO III. Relationships between My cobacterium isolates from patients with pulmonarymycobacterial infection and potting soils. Appl Environ Microbiol2006;72: 7602-7606.
38. Leber A, Marras TK. The cost of medical management of pulmonarynontuberculous mycobacterial disease in Ontario, Canada. EurRespir J 2011;37: 1158-1165.
39. Zhou Y, Benson JM, Irvin C, Irshad H, Cheng Y-S. Particle sizedistribution and inhalation dose of shower water under selectedoperating conditions. Inhal Toxicol 2007;19: 333-342.
40. Rodgers MR, Blackstone BJ, Reyes AL, Covert TC. Colonisation ofpoint of use water filters by silver resistant non-tuberculousmycobacteria. J Clin Pathol 1999;52: 629.
41. Pryor M, Springthorpe S, Riffard S, Brooks T, Huo Y, Davis G, SattarSA. Investigation of opportunistic pathogens in municipal drinkingwater under different supply and treatment regimes. Water SciTechnol 2004;50: 83-90.
42. Adjemian J, Olivier KN, Seitz AE, Falkinham JO III, Holland SM, Prevots DR. Spatial clusters of nontuberculous mycobacterial lungdisease in the United States. Am J Respir Crit Care Med 2012;186: 553-558.
43. Mijs W, de Haas P, Rossau R, Van der Laan T, Rigouts L, Portaels F, van Soolingen D. Molecular evidence to support a proposal toreserve the designation Mycobacterium avium subsp. avium forbird-type isolates and 'M. avium subsp. hominissuis' for the human/porcine type of M. avium. Int J Syst Evol Microbiol 2002;52: 1505-1518.
44. Murcia MI, Tortoli E, Menendez MC, Palenque E, Garcia MJ.Mycobacterium colombiense sp. nov., a novel member of theMycobacterium avium complex and description of MAC-X as a newITS genetic variant. Int J Syst Evol Microbiol 2006;56: 2049-2054.
45. Tortoli E, Rindi L, Garcia MJ, Chiaradonna P, Dei R, Garzelli C, Kroppenstedt RM, Lari N, Mattei R, Mariottini A, et al. Proposal toelevate the genetic variant MAC-A, included in the Mycobacteriumavium complex, to species rank as Mycobacterium chimaera sp.nov. Int J Syst Evol Microbiol 2004;54: 1277-1285.
46. van Ingen J, Boeree MJ, Kösters K, Wieland A, Tortoli E, DekhuijzenPN, van Soolingen D. Proposal to elevate Mycobacterium aviumcomplex ITS sequevar MAC-Q to Mycobacterium vulneris sp. nov.Int J Syst Evol Microbiol 2009;59: 2277-2282.
47. Bang D, Herlin T, Stegger M, Andersen AB, Torkko P, Tortoli E, Thomsen VO. Mycobacterium arosiense sp. nov., a slowly growing, scotochromogenic species causing osteomyelitis in animmunocompromised child. Int J Syst Evol Microbiol 2008;58: 2398-2402.
48. Ben Salah I, Cayrou C, Raoult D, Drancourt M. Mycobacterium marseillense sp. nov., Mycobacterium timonense sp. nov. andMycobacterium bouchedurhonense sp. nov., members of the Mycobacterium avium complex. Int J Syst Evol Microbiol 2009;59: 2803-2808.